Abnormalities of the fetal heart rhythm: irregular rhythm and the most common fetal tachyarrhythmias

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Abnormalities of the rhythm and conduction of the fetal heart are detected quite rarely, namely, in 1–5% of pregnancies, according to various authors. In more than 90% of cases, arrhythmias are short-term and single episodes that have little clinical significance. However, about 10% of all arrhythmias are potentially life-threatening to the fetus. The mechanisms of heart rhythm disorders can be divided into abnormalities in the generation and abnormalities in the electrical impulse conduction. Rhythm disorders caused by the SA node refer to arrhythmias when the sinus node operate at an unusually fast or slow speed, that is, sinus tachy- or bradyarrhythmias. Ectopic heart rhythms (extrasystoles) occur when the pacer shifts from the SA node to the latent pacer. Abnormal pulse propagation is the circular propagation of an impulse around additional pathways – re-entry (supraventricular tachycardia, atrial flutter) or a disorder in the conduction of the pulse through the conduction system of the heart (AV block). Fetal arrhythmias usually refer to an irregular rhythm with a normal fetal heart rate (HR), tachyarrhythmia, defined as heart rate >180 beats/min, and bradyarrhythmia, defined as heart rate<110 beats/min. Fetal tachyarrhythmias can be divided into sinus tachycardia, supraventricular tachycardia, ventricular tachycardia. Many cases of abnormal fetal heart rhythm are of minor clinical significance, however, prolonged tachyarrhythmias or arrhythmias with ventricular heart rate of more than 200 beats per minute often cause heart failure and hydrops fetalis.

Conclusion: Fetal arrhythmias are serious conditions that require treatment to prevent heart failure and fetal death. It is necessary to perform ultrasound examination of the fetal heart to understand the main mechanism of rhythm disorders, to study the effect of arrhythmia on cardiac function, as well as to monitor the condition of the fetus during antiarrhythmic treatment.

Full Text

Restricted Access

About the authors

Natalia E. Yannaeva

Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Author for correspondence.
Email: yannaeva@yandex.ru

PhD, ultrasound diagnostics doctor, Senior Researcher

Russian Federation, 117997, Moscow, Ac. Oparin str., 4

Ekaterina L. Bokeriya

Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: e-bockeria@mail.ru
ORCID iD: 0000-0002-8898-9612

Dr. Med. Sci., Professor, Department of Neonatology, neonatologist, pediatric cardiologist, Leading Researcher

Russian Federation, 117997, Moscow, Ac. Oparin str., 4

References

  1. Jaeggi E., Öhman A. Fetal and neonatal arrhythmias. Clin. Perinatol. 2016; 43(1): 99-112. https://dx.doi.org/10.1016/j.clp.2015.11.007.
  2. Wacker-Gussmann A., Strasburger J.F., Cuneo B.F., Wakai R.T. Diagnosis and treatment of fetal arrhythmia. Am. J. Perinatol. 2014; 7: 617-28. https://dx.doi.org/10.1055/s-0034-1372430.
  3. Wacker-Gussmann A., Strasburger J.F., Srinivasan S., Cuneo B.F., Lutter W., Wakai R.T. Fetal atrial futter: electrophysiology and associations with rhythms involving an accessory pathway. J. Am. Heart Assoc. 2016; 5(6): e003673. https://dx.doi.org/10.1161/JAHA.116.003673.
  4. Бокерия О.Л., Ахобеков А.А. Синдром Вольфа-Паркинсона-Уайта. Анналы Aритмологии. 2015; 12(1): 25-37. [Bockeria O.L., Akhobekov A.A. Wolf-Parkinson-White syndrome. Annaly Aritmologii. 2015; 12(1): 25-37 (in Russian)]. https://dx.doi.org/10.15275/annaritmol.2015.1.4.
  5. Bravo-Valenzuela N.J., Rocha L.A., Machado Nardozza L.M., Araujo Júnior E. Fetal cardiac arrhythmias: current evidence. Ann. Pediatr. Cardiol. 2018; 11(2): 148-63. https://dx.doi.org/10.4103/apc.APC_134_17.
  6. Zhao H., Strasburger J.F., Cuneo B.F., Wakai R.T. Fetal cardiac repolarization abnormalities. Am. J. Cardiol. 2006; 98(4): 491-6. https://dx.doi.org/ 10.1016/j.amjcard.2006.03.026.
  7. Gembruch U. Fetal tachyarrhythmia. In: Yagel S., Silverman N.H., Gembruch U., eds. Fetal Cardiology. 3rd ed. Taylor and Francis, LLC: Boca Raton, FL, USA; 2019.
  8. Strasburger J.F., Cheulkar B., Wichman H.J. Perinatal arrhythmias: diagnosis and management. Clin. Perinatol. 2007; 34(4): 627-52. https://dx.doi.org/ 10.1016/j.clp.2007.10.002.
  9. Srinivasan S., Strasburger J. Overview of fetal arrhythmias. Curr. Opin. Pediatr. 2008; 20(5): 522-31. https://dx.doi.org/10.1097/MOP.0b013e32830f93ec.
  10. Kleinman C.S., Nehgme R.A. Cardiac arrhythmias in the human fetus. Pediatr. Cardiol. 2004; 25(3): 234-51. https://dx.doi.org/ /10.1007/s00246-003-0589-x.
  11. Nagashima M., Matsushima M., Ogawa A., Ohsuga A., Kaneko T., Yazaki T. et al. Cardiac arrhythmias in healthy children revealed by 24-hour ambulatory ECG monitoring. Pediatr. Cardiol. 1987; 8(2): 103-8. https://dx.doi.org/ 10.1007/BF02079464.
  12. Grimaud M., Starck J., Levy M., Marais C., Chareyre J., Khraiche D. et al. Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children. Ann. Intensive Care. 2020; 10(1):69. https://dx.doi.org/10.1186/s13613-020-00690-8.
  13. Irabien-Ortiz A., Carreras-Mora J., Sionis A., Pamies J., Montiel J., Tauron M. Fulminant myocarditis due to COVID-19. Rev. Esp. Cardiol. (Engl Ed). 2020; 73(6): 503-4. https://dx.doi.org/10.1016/j.rec.2020.04.005.
  14. Sonesson S.E., Eliasson H., Conner P., Wahren-Herlenius M. Doppler echocardiographic isovolumetric time intervals in diagnosis of fetal blocked atrial bigeminy and 2:1 atrioventricular block. Ultrasound Obstet. Gynecol. 2014; 44(2):171-5. https://dx.doi.org/10.1002/uog.13344.
  15. Teramachi Y., Maeno Y., Hirose A., Horinouchi T., Kozuma Y., Yoshizato T. et al. Simple method to distinguish the type of fetal premature contraction using arterial Doppler time interval measurements. J. Obstet. Gynaecol. Res. 2021; 47(2): 495-500. https://dx.doi.org/10.1111/jog.14563.
  16. Donofrio M.T., Moon-Grady A.J., Hornberger L.K., Copel J.A., Sklansky M.S., Abuhamad A. et al. Diagnosis and treatment of fetal cardiac disease: а scientific statement from the American Heart Association. Circulation. 2014; 129(21): 2183-242. https://dx.doi.org/10.1161/01.cir.0000437597.44550.5d.
  17. Eliasson H., Wahren-Herlenius M., Sonesson S.E. Mechanisms in fetal bradyarrhythmia: 65 cases in a single center analyzed by Doppler flow echocardiographic techniques. Ultrasound Obstet. Gynecol. 2011; 37(2): 172-8. https://dx.doi.org/10.1002/uog.8866.
  18. Bergman G., Eliasson H., Bremme K., Wahren-Herlenius M., Sonesson S.E. Аnti-Ro52/SSA antibody-exposed fetuses with prolonged atrioventricular time intervals show signs of decreased cardiac performance. Ultrasound Obstet. Gynecol. 2009; 34(5): 543-9. https://dx.doi.org/10.1002/uog.7343.
  19. Vergani P., Mariani E., Ciriello E., Locatelli A., Strobelt N., Galli M. et al. Fetal arrhythmias: natural history and management. Ultrasound Med. Biol. 2005; 31(1): 1-6. https://dx.doi.org/10.1016/j.ultrasmedbio.2004.10.001.
  20. Cuneo B.F. Strasburger J.F., Wakai R.T., Ovadia M. Conduction system disease in fetuses evaluated for irregular cardiac rhythm. Fetal Diagn. Ther. 2006; 21(3): 307-13. https://dx.doi.org/10.1159/000091362.
  21. Jaeggi E.T., Nii M. Fetal brady-and tachyarrhythmias: new and accepted diagnostic and treatment methods. Semin. Fetal Neonatal. Med. 2005; 10(6): 504-14. https://dx.doi.org/10.1016/j.siny.2005.08.003.
  22. Strasburger J.F. Prenatal diagnosis of fetal arrhythmias. Clin. Perinatol. 2005; 32(4):891-912, viii. https://dx.doi.org/10.1016/j.clp.2005.09.011.
  23. Chugh A., Morady F. Preexcitation, atrioiventricular reentry and variants. In: Zipes D.P., Jalife J., Stevenson W.G., eds. Cardiac electrophysiology: from cell to bedside. 7th ed. Philadelphia: Elsevier; 2018: 755-65. https://dx.doi.org/10.1016/B978-1-4557-2856-5.00076-5.
  24. Miyake A., Sakaguchi H., Miyazaki A., Miyoshi T., Aiba T., Shiraishi I. Successful prenatal management of ventricular tachycardia and second-degree atrioventricular block in fetal long QT syndrome. HeartRhythm Case Rep. 2016;3(1):53-7. https://dx.doi.org/10.1016/j.hrcr.2016.09.001.
  25. Simpson J.M., Maxwell D., Rosenthal E., Gill H. Fetal ventricular tachycardia secondary to long QT syndrome treated with intravenous magnesium: case report and review of the literature. Ultrasound Obstet. Gynecol. 2009; 34(4): 475-80. https://dx.doi.org/10.1002/uog.6433.
  26. Takahashi K., Shiraishi H., Ohkuchi A., Matsubara S., Kuwata T., Yada Y. et al. Irregular peak-to-peak intervals between ascending aortic flows during fetal ventricular tachycardia in long QT syndrome. Ultrasound Obstet. Gynecol. 2009; 33(1): 118-20. https://dx.doi.org/10.1002/uog.6263.
  27. Simpson J.M. Fetal arrhythmias. Ultrasound Obstet. Gynecol. 2006; 27(6): 599-606. https://dx.doi.org/10.1002/uog.2819.
  28. Miyake C.Y., Del Nido P.J., Alexander M.E., Cecchin F., Berul C.I., Triedman J.K. et al. Cardiac tumors and associated arrhythmias in pediatric patients, with observations on surgical therapy for ventricular tachycardia. J. Am. Coll. Cardiol. 2011; 58(18): 1903-9. https://dx.doi.org/10.1016/ j.jacc.2011.08.005.
  29. Swann O.V., Holden K.A., Turtle L., Pollock L., Fairfield C.J., Drake T.M. et al. Clinical characteristics of children and young people admitted to hospital with Covid-19 in United Kingdom: prospective multicenter observational cohort study. BMJ. 2020; 370: m3249. https://dx.doi.org/10.1136/bmj.m3249.
  30. Вязова Л.И., Башлакова А.Н. Антенатальные миокардиты у детей. Известия Национальной академии наук Беларуси. Серия медицинских наук. 2017; (4): 111-9. [Viazova L.I., Bashlakova A.N. Anthenatal myocarditises of children. Proceedings of the National Academy of Sciences of Belarus. Medical series. 2017; (4): 111-9 (in Russian)].
  31. Gilbert-Barness E., Barness L.A. Pathogenesis of cardiac conduction disorders in children genetic and histopathologic aspects. Am. J. Med. Genet. A. 2006; 140(19): 1993-2006. https://dx.doi.org/10.1002/ ajmg.a.31440.
  32. Cuneo B.F., Ovadia M., Strasburger J.F., Zhao H., Petropulos T., Schneider J. et al. Prenatal diagnosis and in utero treatment of torsades de pointes associated with congenital long QT syndrome. Am. J. Cardiol. 2003; 91(11):1395-8. https://dx.doi.org/10.1016/S0002-9149(03)00343-6.
  33. Krаpp M., Kohl T., Simpson J.M., Sharland G.K., Katalinic A., Gembruch U. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart. 2003; 89(8): 913-7. https://dx.doi.org/10.1136/heart.89.8.913.
  34. Cuneo B.F. Strasburger J.F., Wakai R.T., Ovadia M. Conduction system disease in fetuses evaluated for irregular cardiac rhythm. Fetal Diagn. Ther. 2006; 21(3): 307-13. https://dx.doi.org/10.1159/000091362.
  35. Abuhamad A., Chaoui R. Fetal arrhythmias. In: Abuhamad A., Chaoui R., editors. A practical guide to fetal echocardiography normal and abnormal hearts. 3rd ed. Wolters Kluwer; Philadelphia, PA, USA. 2016: 547-63.
  36. Lisowski L.A., Verheijen P.M., Benatar A.A., Soyeur D.J., Stoutenbeek P., Brenner J.I. et al. Atrial flutter in the perinatal age group: diagnosis, management and outcome. J. Am. Coll. Cardiol. 2000; 35(3): 771-7. https://dx.doi.org/10.1016/s0735-1097(99)00589-6.
  37. Cuneo B.F., Strasburger J.F. Management strategy for fetal tachycardia. Obstet. Gynecol. 2000; 96(4): 575-81. https://dx.doi.org/10.1016/ s0029-7844(00)00996-0.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig.1.

Download (495KB)
3. Fig.2.

Download (402KB)
4. Fig.3.

Download (240KB)
5. Fig.4.

Download (460KB)
6. Fig.5.

Download (268KB)
7. Fig.6.

Download (354KB)
8. Fig.7.

Download (337KB)
9. Fig.8.

Download (229KB)

Copyright (c) 2023 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies